ICM
BATRK icon

Invenomic Capital Management’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Invenomic Capital Management’s Portfolio BATRK Stock Details BATRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,087
Closed -$249K – 155
2020
Q1 		$249K Buy
+13,087
New +$336K 0.2% 112

Other funds holding BATRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invenomic Capital Management's BATRK Position: Q2 2020 in Review

Invenomic Capital Management sold out of Atlanta Braves Holdings Series B (BATRK) in Q2 2020, closing a stake of 13,087 shares — an estimated $249K sold.

Invenomic Capital Management first reported a position in BATRK in Q1 2020 and held it in 1 quarter. The position peaked at $249K in Q1 2020. 175 funds tracked by Wall St. Rank hold BATRK as of Q2 2020.

  • Invenomic Capital Management reported no remaining Atlanta Braves Holdings Series B position as of Q2 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 13,087 Atlanta Braves Holdings Series B shares in Q2 2020, an estimated $249K.
  • Invenomic Capital Management first reported a position in Atlanta Braves Holdings Series B in Q1 2020 and held it in 1 quarter.
  • Invenomic Capital Management's Atlanta Braves Holdings Series B position peaked at $249K in Q1 2020.
  • 175 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q2 2020.

Based on Invenomic Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.